Cargando…

Omalizumab is effective in nasal polyposis with or without asthma, a real-life study

BACKGROUND: Chronic rhinosinusitis with nasal polyposis (CRSwNP) can be recalcitrant in some patients despite medical therapies and surgery and has higher morbidity. Omalizumab is a new treatment option for patients with CRSwNP. The aim of this study is to evaluate the efficacy and safety of omalizu...

Descripción completa

Detalles Bibliográficos
Autor principal: Tat, Tuğba Songül
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382317/
https://www.ncbi.nlm.nih.gov/pubmed/36017064
http://dx.doi.org/10.1016/j.waojou.2022.100670